Study Investigates Optimal Dosing for MDMA

Study Investigates Optimal Dosing for MDMA

Potential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.
UCSF Launches Psychedelic Research Institute

UCSF Launches New Psychedelic Research Division

Psychedelic research is coming to the University of California in a new division to study MDMA.
Mass General to Study Psilocybin

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.
Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

,
The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?
Use of Psychedelic Shows Correlation With Better Overall Physical Health

Use of Psychedelics Show Correlation With Better Overall Physical Health

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.
Low Doses of LSD Make Opioids Obsolete

Are Stereotypes Around Psychedelics Slowing Down Research?

Psychedelics come with history as party drugs. Are these stigmas slowing down progress?
Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

New Research Investigates Psilocybin as OCD Treatment

,
Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).
Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

,
Psychedelic use may help to decrease the risk of hypertension, according to new research.
psychedelic mushrooms

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

,
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.
MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

,
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.